Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

Avelumab or M7824 for People with Recurrent Respiratory Papillomatosis

Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis

C. Allen, Sunmin Lee, S. Norberg, et al. (2019). Journal for Immunotherapy of Cancer. Cited 46 times. https://doi.org/10.1186/s40425-019-0603-3

Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis

Y. Robbins, J. Friedman, Paul E Clavijo, et al. (2021). Journal for Immunotherapy of Cancer. Cited 14 times. https://doi.org/10.1136/jitc-2021-003113